|
BTBD7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66577862614758E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02120542525108E-11 |
| Normal-vs-Stage2 |
1.422480E-04 |
| Normal-vs-Stage3 |
1.86206605690131E-12 |
| Normal-vs-Stage4 |
2.86415335892798E-12 |
| Stage1-vs-Stage2 |
1.715370E-01 |
| Stage1-vs-Stage3 |
1.116570E-01 |
| Stage1-vs-Stage4 |
1.881330E-03 |
| Stage2-vs-Stage3 |
1.763740E-02 |
| Stage2-vs-Stage4 |
1.279580E-03 |
| Stage3-vs-Stage4 |
1.697370E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.31006316905768E-14 |
| Normal-vs-AfricanAmerican |
2.003800E-04 |
| Normal-vs-Asian |
1.85070000435772E-08 |
| Caucasian-vs-AfricanAmerican |
4.269200E-01 |
| Caucasian-vs-Asian |
8.287800E-01 |
| AfricanAmerican-vs-Asian |
5.518000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.50379716959515E-11 |
| Normal-vs-Female |
2.11308748276906E-12 |
| Male-vs-Female |
4.998000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.97159971576855E-10 |
| Normal-vs-Age(41-60Yrs) |
1.54329882207094E-11 |
| Normal-vs-Age(61-80Yrs) |
2.27460272839153E-11 |
| Normal-vs-Age(81-100Yrs) |
7.177800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.214400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.688600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.088000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.316000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.351400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.757000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.504140E-03 |
| Classical-VS-Follicular |
3.846400E-01 |
| Classical-VS-Other |
4.304800E-01 |
| Classical-VS-Normal |
2.91067170365977E-12 |
| Tall-VS-Follicular |
1.396140E-03 |
| Tall-VS-Other |
5.300000E-01 |
| Tall-VS-Normal |
1.39850353519932E-11 |
| Follicular-VS-Other |
3.585200E-01 |
| Follicular-VS-Normal |
2.31729999999875E-06 |
| Other-VS-Normal |
2.344800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.69859723245736E-11 |
| Normal-vs-N1 |
9.61799528909069E-11 |
| N0-vs-N1 |
6.042400E-02 |
|
|
